Apellis Pharmaceuticals, Inc. — SCHEDULE 13G/A Filings
6 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Apellis Pharmaceuticals, Inc. (APLS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Apellis Pharmaceuticals, Inc. has filed 6 SCHEDULE 13G/A documents with the SEC since 2019. To view all SEC filings by Apellis Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000675 | Mar 26, 2026 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000697 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000371 | Nov 7, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000281 | Aug 12, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-001714 | Apr 25, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000121 | Feb 10, 2025 | — |